Logo.png
GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor – The GRI Opportunity Spotlight Event
July 24, 2023 09:00 ET | GRI Bio, Inc.
- Live moderated webcast with members of the GRI Bio management team on Thursday, July 27th at 1:00 PM ET LA JOLLA, CA, July 24, 2023 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio”...
Research Nester Logo.jpg
Bispecific Antibody Market revenue to cross USD 1 Billion by 2035, says Research Nester
July 24, 2023 07:00 ET | Research Nester
New York, July 24, 2023 (GLOBE NEWSWIRE) -- The global bispecific antibody market size is slated to expand at ~7% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 1...
TolerogenixX expands Phase II immune-tolerance trial and closes EUR 12 million Series A financing
July 06, 2023 04:00 ET | AKAMPION
Ongoing Phase IIb study expands to arm B5-year results of phase I study confirm efficacy and safety of novel immune-tolerance inducing cell therapy in organ transplantationSecond closing of Series A...
GMILogo_Vertical-Gradient.png
Photopheresis Products Market to exceed USD 488 billion by 2032, says Global Market Insights Inc.
June 27, 2023 07:00 ET | Global Market Insights Inc.
Selbyville, Delaware, June 27, 2023 (GLOBE NEWSWIRE) -- Photopheresis Products Market size is predicted to surpass USD 488 billion by 2032. Advancements in medical technology and increasing demand...
MicrosoftTeams-image (5).png
Autoinjectors Market to Grow at 16.2% CAGR and Reach USD 3.8 Bn by 2031 | Excusive Research by Transparency Market Research
June 15, 2023 10:30 ET | Transparency Market Research
Wilmington, Delaware, United States, June 15, 2023 (GLOBE NEWSWIRE) -- The global autoinjectors market was valued at USD 1.0 Bn in 2022 and is projected to grow at a CAGR of 16.2% from 2023 to 2031....
MicrosoftTeams-image (5).png
Lyophilized Injectable Market Primed to Surpass USD 5 Billion by 2031, According to Transparency Market Research
June 05, 2023 06:30 ET | Transparency Market Research
Wilmington, Delaware, United States, June 05, 2023 (GLOBE NEWSWIRE) -- The global lyophilized injectable market is projected to exceed value of US$ 5 Bn by 2031. It is expected to expand at a CAGR...
selectION, Inc., Reports Interim Safety and Tolerability Results of Phase 1b Clinical Trial in Atopic Dermatitis
May 30, 2023 04:00 ET | AKAMPION
Ongoing phase 1b trial is designed to evaluate safety, tolerability, and efficacy of si-544 in T-cell mediated autoimmunity Dosing of MAD stage has been initiated; first results expected for late...
ImmunOs Therapeutics Announces Initiation of Dosing in Phase 1 Trial of Lead Compound IOS-1002
May 24, 2023 04:00 ET | AKAMPION
- First-in-class checkpoint inhibitor IOS-1002 (targeting LILRB1 (ILT2), LILRB2 (ILT4), KIR3DL1) being evaluated as mono and combination therapy in patients with advanced solid tumors Schlieren...
Vantage Market Research.png
Monoclonal Antibodies Market Size & Share to Surpass $155.2 Billion by 2028 | Vantage Market Research
April 10, 2023 05:10 ET | Vantage Market Research
WASHINGTON, April 10, 2023 (GLOBE NEWSWIRE) -- The Global Monoclonal Antibodies Market is valued at USD 111.93 Billion in 2022 and is projected to reach a value of USD 186.67 Billion by 2030 at a...
BiondVax LOGO.png
BiondVax to Present at BIO-Europe Spring
March 16, 2023 13:10 ET | BiondVax Pharmaceuticals Ltd.
JERUSALEM, March 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing...